This is the record of iPS Bio’s path
to lead the world through
innovation and passion.





- Jul
-
Company established

- Mar
-
Approved as a Venture Business
- Apr
-
Corporate Institute accreditation
- Jun
-
Awarded TIPS grant
- Jul
-
Awarded BIG3 grant
- Jan
-
Awarded IPK Bio-Core Facility grant
- Mar
-
Secured Series A funding (8 Billion KRW)
Selected for Excellent Technology Evaluation Company
- Nov
-
Awarded from the Minister of Health and Welfare for
commercialization of health industry technology
- Jan
-
Selected for BIG3 Innovative Start-Up Package
- Apr
-
Awarded Korean Fund for Regenerative Medicine grant
(Huntington's disease)
- Jun
-
Awarded BIG3 grant (Market Expansion)
- Dec
-
Awarded Regenerative Medicine Clinical Research Infrastructure
Development grant

- Jan
-
Awarded Health and Medical Technology R&D Program:
Establishment of Infrastructure for Clinical Research in
Regenerative Medicine
- Mar
-
Relocated to New Headquarters
- Apr
-
Awarded Korean Fund for Regenerative Medicine grant (Stroke)
Awarded Research and Development Project Funded by the
Ministry of Food and Drug Safety
- Jun
-
Recognized for New Excellent Technology (NET) for Health
- Aug
-
Awarded Global Innovation Zone Overseas Demonstration grant
(Non-R&D)Awarded Post-TIPS grant
- Sep
-
Awarded Global Innovation Zone Overseas Demonstration grant
(R&D)